OTO-104
Drug
Otonomy, Inc.
Total Payments
$333,267
Transactions
97
Doctors
13
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $293,379 | 87 | 13 |
| 2019 | $39,888 | 10 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $214,522 | 71 | 64.4% |
| Consulting Fee | $118,745 | 26 | 35.6% |
Payments by Type
Research
$214,522
71 transactions
General
$118,745
26 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease | Otonomy, Inc. | $209,072 | 11 |
| A prospective, randomized, double blind, placebo-controlled, multicenter, Phase 3 efficacy and safetystudy of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere's disease. | Otonomy, Inc. | $5,450 | 0 |
Top Doctors Receiving Payments for OTO-104
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Aurora, CO | $213,673 | 60 |
| , MD | Clinical Pharmacology | San Diego, CA | $63,270 | 14 |
| Stephen Bradley | — | La Jolla, CA | $55,475 | 12 |
| , M.D | Otolaryngology | Charlotte, NC | $350.00 | 1 |
| , MD | Otolaryngology | Cornelius, NC | $350.00 | 1 |
| , M.D | Otolaryngology | Murfreesborooy, TN | $26.80 | 1 |
| , MD | Specialist | Getzville, NY | $19.19 | 1 |
| , M.D | Specialist | Buffalo, NY | $19.19 | 1 |
| Christopher Cote | Otolaryngology | Castle Rock, CO | $16.13 | 1 |
| Alan Lipkin | Otolaryngology | Castle Rock, CO | $16.13 | 1 |
| , MD | General Practice | Denver, CO | $16.13 | 1 |
| , MD | Otolaryngology | Williamsville, NY | $11.92 | 1 |
| , MD PHD | Student in an Organized Health Care Education/Training Program | Williamsville, NY | $11.92 | 1 |
| , MD | Internal Medicine | Buffalo, NY | $11.92 | 1 |
Ad
Manufacturing Companies
- Otonomy, Inc. $333,267
Product Information
- Type Drug
- Total Payments $333,267
- Total Doctors 13
- Transactions 97
About OTO-104
OTO-104 is a drug associated with $333,267 in payments to 13 healthcare providers, recorded across 97 transactions in the CMS Open Payments database. The primary manufacturer is Otonomy, Inc..
Payment data is available from 2019 to 2020. In 2020, $293,379 was paid across 87 transactions to 13 doctors.
The most common payment nature for OTO-104 is "Unspecified" ($214,522, 64.4% of total).
OTO-104 is associated with 2 research studies, including "A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease" ($209,072).